Engineering non-antibody human proteins as efficient scaffolds for selective, receptor-targeted drug delivery
Authors:
- 17 January 2022
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 343, 277-287
Abstract
No abstract availableKeywords
Funding Information
- Universitat Autònoma de Barcelona
- European Regional Development Fund (BIO2016-76063-R)
- European Regional Development Fund (PID2019-105416RB-I00/AEI/10.13039/501100011033)
- Institució Catalana de Recerca i Estudis Avançats
- Fundació la Marató de TV3
- Ministerio de Ciencia, Innovación y Universidades (FPU18/04615)
- Agència de Gestió d'Ajuts Universitaris i de Recerca (2017SGR-865)
- Agència de Gestió d'Ajuts Universitaris i de Recerca (2017SGR-1395)
- Agència de Gestió d'Ajuts Universitaris i de Recerca (2017SGR-229)
- Agencia Estatal de Investigación (BIO2016-76063-R)
- Center for International Business Education and Research, University of Illinois at Urbana-Champaign
- Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina
- Fundación Científica Asociación Española Contra el Cáncer
- European Social Fund Plus
- International Centre for Theoretical Sciences
- Gobierno de Navarra
- Instituto de Salud Carlos III (PI18/00650)
- Instituto de Salud Carlos III (PI20/00400)
- Instituto de Salud Carlos III (CP19/00028)
- Instituto de Salud Carlos III (201941-30-31-32)
- Centro para el Desarrollo Tecnológico Industrial (RTC-2017-6125-1)
- National Institutes of Health (P41-GM103311)
- Institute for Bioengineering and Biosciences
This publication has 51 references indexed in Scilit:
- In VivoArchitectonic Stability of Fullyde NovoDesigned Protein-Only NanoparticlesACS Nano, 2014
- Non-amyloidogenic peptide tags for the regulatable self-assembling of protein-only nanoparticlesBiomaterials, 2012
- Discovery of small molecule cancer drugs: Successes, challenges and opportunitiesMolecular Oncology, 2012
- Designing super selectivity in multivalent nano-particle bindingProceedings of the National Academy of Sciences, 2011
- Designing a Long Acting Erythropoietin by Fusing Three Carboxyl-Terminal Peptides of Human Chorionic GonadotropinSubunit to theN-Terminal andC-Terminal Coding SequenceInternational Journal of Cell Biology, 2011
- Immunogenicity of protein therapeutics: The key causes, consequences and challengesSelf/Nonself, 2010
- Renal clearance in drug discovery and development: molecular descriptors, drug transporters and disease stateExpert Opinion on Drug Metabolism & Toxicology, 2010
- Structure-function studies of an engineered scaffold protein derived from stefin A. I: Development of the SQM variantProtein Engineering, Design and Selection, 2010
- Design and Validation of a Neutral Protein Scaffold for the Presentation of Peptide AptamersJournal of Molecular Biology, 2005
- Protein structure prediction and analysis using the Robetta serverNucleic Acids Research, 2004